Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Generate Biomedicines reports Q2 2026 results, advances asthma and oncology pipelineAug 6Quarterly updateGenerate Biomedicines